WEX: Impactive Funds sell 200,000 shares at $181
The securities were held by certain Impactive Funds, which delegated voting and investment power to Impactive Capital.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
WEX Inc. common stock held directly by certain Impactive Funds was sold in two reported transactions: 200,000 shares at $181 per share on November 5, 2026, and 34,577 shares at $184.19 per share on November 6, 2026. The transactions were reported jointly by Impactive Capital LP, Impactive Capital LLC, and directors by deputization Christian Asmar and Lauren Taylor Wolfe. The funds delegated voting and investment power to Impactive Capital, and the reporting persons disclaimed beneficial ownership except to the extent of their pecuniary interests. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 34,577 | $184.19 | $6.37M |
| Sale | Common Stock F1, F2 | 200,000 | $181.00 | $36.20M |
Footnotes (2)
- F1. This Form 4 is filed jointly by Impactive Capital LP ("Impactive Capital"), Impactive Capital LLC ("Impactive GP"), Christian Asmar and Lauren Taylor Wolfe (collectively, the "Reporting Persons"). Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of her, his or its pecuniary interest therein.
- F2. The securities of WEX Inc. (the "Issuer") reported herein are held directly by certain funds and/or accounts (the "Impactive Funds"). Pursuant to an Investment Management Agreement, the Impactive Funds have delegated all voting and investment power over the securities directly held by the Impactive Funds and their general partners to Impactive Capital, which serves as the investment manager of the Impactive Funds. Impactive GP, as the general partner of Impactive Capital, and each of Mr. Asmar and Ms. Taylor Wolfe, as Managing Members of Impactive GP, may be deemed to exercise voting and investment power over such securities. The Impactive Funds specifically disclaim beneficial ownership of such securities by virtue of their inability to vote or dispose of such securities as a result of such delegation to Impactive Capital.
Key Figures
Key Terms
director by deputization regulatory
pecuniary interest technical
Investment Management Agreement technical
voting and investment power technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.